To date, CDBT has created 27 platforms for drug screening, discovery, and
product manufacturing, and has provided over 1,000 rounds of services for
enterprises both at home and abroad.Upgrading the value chain: Focusing on
satisfying clinical needs
Meanwhile, to encourage research that satisfies clinical demands, CDBT has
proactively built the Tianfu International Medical Center, which comprises several
hospitals and is aimed at building a bridge between labs and hospitals and
harboring international multicenter clinical trials. Through the Medical Center,
innovative R&D achievements from labs can be transferred to clinical applications
in hospitalsóachievements that are also based on hospitalsí clinical demands in
the real world. CDBT has established Chinaís first clinical drug trial investigator
association and good clinical practice (GCP) company. It has also established the
BOE Digital Hospital and is speeding up construction of the West China Heavy
Proton and Ion Hospital as well as the Sichuan Provincial Maternal and Child
Health Care Hospital.Suppy chain: Advantages brought by the ìLand
of Abundanceî
Chengdu has provided CDBT with many advantages, and one of them is
preferential location with busy air and ground transportation.
As a critical city in Chinaís One Belt, One Road Initiative, Chengdu is now the
third Chinese city with two international airports. Since 2017, its Chengduñ
Europe Express has been able to reach Lodz, Poland, in 15 days. Chengdu is also
the fourth Chinese port approved for biological products import. CDBT is the
first industrial zone in China to have a Biomedical Supply Chain Industrialization
Service Center. All these factors have made pharmaceutical companies such as
Allergan and CSL Behring choose Chengdu as the place for Customs clearance.Emphasizing the importance of human
resources and financial supports
Also critical to the development of CDBT is human resources. CDBT sees highly
skilled individuals as the primary core factor in industrial innovation and hascultivated a competitive reward policy for talented researchers. At present, CDBT
has gathered more than 60,000 various talents in different industries, including
five teams led by Nobel Prize laureates and 10 teams led by academicians.
To make these talents feel at home, CDBT has built a complete production-
guaranteed service system in terms of hazardous waste treatment, energy
guarantee, and 5G network. It is attentive to the construction of living facilities
and is committed to building a 15-minute comprehensive business circle and a
5-minute basic living circle (i.e., people can reach their offices in a 15-minute walk
and their living facilities , such as apartments, international schools and high-end
hospitals, in a 5-minute walk).
CDBT actively creates innovative financial products and models, establishing
Chinaís first biomedical insurance supermarket and introducing specialized funds.
It has also developed a Bio Loan series of financial products suitable for early-
stage loans, aimed at helping small and medium-sized enterprises expand their
financing channels. Meanwhile, the Provincial Medical Products Administration
has set up service stations in CDBT that help facilitate faster approval of medical
products.Join us
CDBT is committed to creating value for biological industries worldwide. We
sincerely invite experts, entrepreneurs, and everyone interested in promoting the
medical and health-related industry to visit and to settle down and participate in
its further development.Produced by the Science
IMAGES PROVIDED BY CHENGDUSponsored by1029Product.indd 505 10/21/21 7:28 AM